News
GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company ...
Zantac was sold at different times by GSK, Pfizer, Sanofi and Boehringer Ingelheim. First approved by U.S. regulators in 1983, it became the world's best-selling medicine in 1988 and one of the ...
Hosted on MSN11mon
GSK wins latest Zantac trial as jury finds drug did not cause ... - MSNGSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.
U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...
GSK, which faced the largest potential liability, in October agreed to settle about 80,000 Zantac lawsuits it was facing in state courts, representing about 93% of the cases against it, for $2.2 ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
GSK has won its latest trial over whether its former best-selling drug caused cancer on Monday, after a jury found it was not the root cause of an American woman’s illness. Carrie Joiner had alleged ...
Aug 5 (Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's ...
UK-based GlaxoSmithKline PLC (GB:GSK) has won the latest U.S. trial concerning its heartburn drug Zantac (ranitidine), amid litigation over alleged cancer risks. The Florida State Court ruled in ...
GSK has won its latest trial over whether its former best-selling drug caused cancer on Monday, after a jury found it was not the root cause of an American woman’s illness.
(Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results